Streetbeat News

Analyst Ratings

MLM

Martin Marietta Materials's (NYSE:MLM) short percent of float has fallen 23.08% since its last report, with 542 thousand shares sold short, which is 1.0% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards the stock. However, it does not necessarily mean that the stock price will rise in the near term. Compared to its peers, MLM has less short interest as a percentage of float, with an average of 1.74%.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 8:15 pm

SGEN

Seagen's (NYSE:SGEN) short percent of float has risen 11.51% since its last report, with 7.48 million shares sold short, which is 5.33% of all regular shares available for trading. It would take traders 5.38 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. Seagen's peer group average for short interest as a percentage of float is 3.58%, indicating the company has more short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 8:15 pm

FDX

FedEx's (NYSE:FDX) short percent of float has fallen 7.08% since its last report, with 2.43 million shares sold short, which is 1.05% of all regular shares available for trading. It would take traders 1.77 days to cover their short positions on average. FedEx's peer group average for short interest as a percentage of float is 3.39%, indicating that the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 8:15 pm

WAL

Piper Sandler analyst Brad Milsaps has maintained an Overweight rating on Western Alliance (NYSE:WAL) but lowered the price target from $60 to $59.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 8:13 pm

CBAY

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) presented findings from its post-hoc analysis of the Phase 3 ENHANCE study of seladelpar for the treatment of primary biliary cholangitis (PBC). The study showed that treatment with seladelpar is correlated with a significant decrease in both IL-31 levels and levels of patient-reported itch. The company also presented a post-hoc analysis of four seladelpar clinical trials from 2015 to 2022, which found that PBC patients previously treated with ursodeoxycholic acid (UDCA) with elevated alkaline phosphatase (ALP) who did not meet current clinical guidelines for second-line treatment, nevertheless had a significant risk of disease progression.

Portfolio Pulse from Happy Mohamed

October 23, 2023 | 8:11 pm

OKTA

Piper Sandler analyst Rob Owens maintains an Overweight rating on Okta (NASDAQ:OKTA) but has lowered the price target from $100 to $95.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 8:11 pm

OCFC

Piper Sandler analyst Frank Schiraldi has maintained a Neutral rating on OceanFirst Financial (NASDAQ:OCFC) and lowered the price target from $17 to $15.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 8:10 pm

BANF

Piper Sandler analyst Nathan Race maintains an Underweight rating on BancFirst (NASDAQ:BANF) and lowers the price target from $82 to $79.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 8:08 pm

ZI

Piper Sandler analyst Brent Bracelin maintains an Overweight rating on ZoomInfo Technologies (NASDAQ:ZI) but has lowered the price target from $26 to $21.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 8:05 pm

FND

Floor & Decor Hldgs (NYSE:FND) has received various analyst ratings in the last quarter, with 5 bullish, 3 somewhat bullish, 11 indifferent, and 1 somewhat bearish. Over the past 3 months, 20 analysts have offered 12-month price targets for the company, with an average price target of $103.65, a 3.13% decrease from the previous average price target of $107.00.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 8:01 pm